Oops, Y-mAbs Gets a ‘Not Quite Ready’ Letter for Omburtamab Biologics License Application!
Hey there cancer warriors! So you might have heard the news… Y-mAbs has got some news for us Now, I know what you’re thinking. Another day, another biopharmaceutical company making headlines. But this time, it’s different. Y-mAbs Therapeutics, Inc. just announced that the FDA has issued a complete response letter for their Omburtamab Biologics License…